Inventor · disambiguated record
James H. Cook, Ii
Also filed as: COOK II JAMES H · COOK JAMES · COOK JAMES H
11 granted patents·10 pending applications·258 citations·filing 1997–2015
91Inventor score
Files withBRISTOL MYERS SQUIBB CO7BAYER PHARMACEUTICALS CORP4COOK II JAMES H3BAYER AG2MCDONALD IVAR M2
Top patents by PatentIndex Score
21 records- 0193US6787651B2Substituted indoles, pharmaceutical compounds containing such indoles and their use as PPAR-γ binding agentsSMITHKLINE BEECHAM CORP·Filed 2001·Granted Sep 7, 2004·72 cites·14 claims
- 0291US7863291B2Quinuclidine compounds as alpha-7 nicotinic acetylcholine receptor ligandsBRISTOL MYERS SQUIBB CO·Filed 2009·Granted Jan 4, 2011·22 cites·14 claims
- 0388US6218431B1Substituted biphenylsBAYER AG·Filed 1997·Granted Apr 17, 2001·93 cites·6 claims
- 0487US8309577B2Quinuclidine compounds as α-7 nicotinic acetylcholine receptor ligandsCOOK II JAMES H·Filed 2009·Granted Nov 13, 2012·10 cites·18 claims
- 0586US6784167B217-beta-hydroxysteroid dehydrogenase-II inhibitorsBAYER PHARMACEUTICALS CORP·Filed 2001·Granted Aug 31, 2004·35 cites·17 claims
- 0676US8507516B2Azabicyclic compounds as alpha-7 nicotinic acetylcholine receptor ligandsMCDONALD IVAR M·Filed 2010·Granted Aug 13, 2013·4 cites·3 claims
- 0775US8278320B2Azabicyclo[2.2.1]heptane compounds as alpha-7 nicotinic acetylcholine receptor ligandsMCDONALD IVAR M·Filed 2010·Granted Oct 2, 2012·4 cites·14 claims
- 0874US8481555B2Aza-bicyclic amine N-oxide compounds as alpha-7 nicotinic acetylcholine receptor ligand pro-drugsLENTZ KIMBERLEY A·Filed 2011·Granted Jul 9, 2013·6 cites·9 claims
- 0971US6051586ASulfonamide substituted chroman derivatives useful as beta 3 adrenoreceptor agonistsBAYER AG·Filed 1998·Granted Apr 18, 2000·12 cites·11 claims
- 1066US2015094309A1Quinuclidine compounds as alpha-7 nicotinic acetylcholine receptor ligandsBRISTOL MYERS SQUIBB CO·Filed 2014·Application pending·0 cites
- 1165US2014221377A1Quinuclidine Compounds as Alpha-7 Nicotinic Acetylcholine Receptor LigandsBRISTOL MYERS SQUIBB CO·Filed 2014·Application pending·0 cites
- 1262US2013131064A1Quinuclidine Compounds as Alpha-7 Nicotinic Acetylcholine Receptor LigandsBRISTOL MYERS SQUIBB CO·Filed 2013·Application pending·0 cites
- 1359US2016101104A1Quinuclidine compounds as alpha-7 nicotinic acetylcholine receptor ligandsBRISTOL MYERS SQUIBB CO·Filed 2015·Application pending·0 cites
- 1458US2015342935A1Quinuclidine compounds as alpha-7 nicotinic acetylcholine receptor ligandsBRISTOL MYERS SQUIBB CO·Filed 2015·Application pending·0 cites
- 1556US2012035178A1Quinuclidine Compounds as Alpha-7 Nicotinic Acetylcholine Receptor LigandsCOOK II JAMES H·Filed 2011·Application pending·0 cites
- 1656US2012035189A1Quinuclidine Compounds as Alpha-7 Nicotinic Acetylcholine Receptor LigandsCOOK II JAMES H·Filed 2011·Application pending·0 cites
- 1752US6903218B2Sulfonamide substituted chroman derivativesBAYER PHARMACEUTICALS CORP·Filed 2003·Granted Jun 7, 2005·0 cites·5 claims
- 1846US10174052B2Quinuclidine compounds as α-7 nicotinic acetylcholine receptor ligandsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Jan 8, 2019·0 cites·13 claims
- 1945US2003073839A1Compounds useful for preparation of Beta-3 adrenoreceptor agonistFiled 2000·Application pending·0 cites
- 2044US2007105851A1Indolyl-thienopyrazinone derivatives useful for treating hyperproliferative disorders and diseases associated with angiogenesisBAYER PHARMACEUTICALS CORP·Filed 2004·Application pending·0 cites
- 2143US2006004011A1Indolyl pyrazinone derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesisBAYER PHARMACEUTICALS CORP·Filed 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when James H. Cook, Ii files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →